Driscoll D - Search Results

1

Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute.

Sharma S, Odunsi K, Driscoll D, Lele S. Sharma S, et al. Among authors: driscoll d. Int J Gynecol Cancer. 2005 May-Jun;15(3):475-82. doi: 10.1111/j.1525-1438.2005.15311.x. Int J Gynecol Cancer. 2005. PMID: 15882172 Free article.

2

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Anupol N, et al. Among authors: driscoll d. Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653. Gynecol Oncol. 2002. PMID: 12051879

3

Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients.

Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S. Sharma S, et al. Among authors: driscoll d. Am J Obstet Gynecol. 2005 Dec;193(6):2077-82. doi: 10.1016/j.ajog.2005.06.074. Am J Obstet Gynecol. 2005. PMID: 16325619

4

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL. Odunsi KO, et al. Among authors: driscoll dl. Eur J Gynaecol Oncol. 2001;22(5):325-30. Eur J Gynaecol Oncol. 2001. PMID: 11766731

5

Primary fallopian tube carcinoma: a retrospective clinicopathologic study.

Singhal P, Odunsi K, Rodabaugh K, Driscoll D, Lele S. Singhal P, et al. Among authors: driscoll d. Eur J Gynaecol Oncol. 2006;27(1):16-8. Eur J Gynaecol Oncol. 2006. PMID: 16550961

6

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.

Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Driscoll D, Marchetti D, Baker T, Lele S. Odunsi K, et al. Among authors: driscoll d. Int J Gynecol Cancer. 2004 Jul-Aug;14(4):659-64. doi: 10.1111/j.1048-891X.2004.14420.x. Int J Gynecol Cancer. 2004. PMID: 15304162

7

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

Villella J, Marchetti D, Odunsi K, Rodabaugh K, Driscoll DL, Lele S. Villella J, et al. Among authors: driscoll dl. Gynecol Oncol. 2004 Dec;95(3):539-45. doi: 10.1016/j.ygyno.2004.07.056. Gynecol Oncol. 2004. PMID: 15581960

8

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Among authors: driscoll d. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

9

Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.

Collins Y, Tan DF, Pejovic T, Mor G, Qian F, Rutherford T, Varma R, McQuaid D, Driscoll D, Jiang M, Deeb G, Lele S, Nowak N, Odunsi K. Collins Y, et al. Among authors: driscoll d. Int J Mol Med. 2004 Jul;14(1):43-53. Int J Mol Med. 2004. PMID: 15202015

10

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. Tammela J, et al. Among authors: driscoll d. Cancer Immun. 2004 Oct 18;4:10. Cancer Immun. 2004. PMID: 15487888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters